Treadmill Training and Quality of Life in Parkinson's Disease

Treadmill Walking Training With Additional Body Load Improves Quality of Life in Subjects With Parkinson's Disease

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00890669

Enrollment

Registered

2009-04-30

Start date

2007-08-31

Completion date

2008-12-31

Last updated

2009-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

treadmill training, body load, quality of life, Parkinson's disease, Motor Symptoms

Brief summary

Parkinson's disease (PD) causes motor and non-motor impairments that affect the quality of life of the subjects. The purpose was to assess the effects of treadmill walking training with additional body load on the quality of life and motor symptoms of the subjects with PD. Methods: Nine subjects with PD, Hoehn and Yahr stages 2 through 3, not demented and with capability to ambulate independently voluntarily participate in this study. The training program was divided into three phases (A1-B-A2): treadmill training with additional body load (A1), control condition (conventional physical therapy group) (B) and treadmill training with load again (A2). Each phase lasted six weeks. The quality of life and motor symptoms were assessed by PDQ-39 and UPDRS, respectively. Both evaluations and training were performed during on-phase of the medication cycle.

Interventions

OTHERTreadmill walking training with additional body load

The training program was divided into three phases (A1-B-A2): * treadmill training with additional body load (A1), * control condition (conventional physical therapy group) (B). and * treadmill training with additional body load again (A2). Each phase lasted six weeks, totaling 18 weeks. Both evaluations and training were performed during on-phase of the medication cycle.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

51 Years to 81 Years

Healthy volunteers

Inclusion criteria

* Hoehn and Yahr (H-Y) stages 2 through 3 * Absence of dementia (Mini-Mental Status Examination - MMSE, defined according to educational level) * Capacity to ambulate independently for at least 10 meters

Exclusion criteria

* Change medication (dopaminergic) during the study period * Use treadmill for at least six months prior to the study * Other neurologic problems or musculoskeletal, cardiovascular and respiratory disease or uncorrected visual deficit that could represent risk and interfere in the accomplishment of the training

Design outcomes

Primary

Measure	Time frame
The quality of life was measured through Parkinson Disease Questionnaire (PDQ-39).	4 times, once before treatment, and 3 after each treatment phase.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026